Frailty and infection in the elderly: Which relations?;Fragilité et infection chez le sujet âgé: quelles relations ?

Cahiers de l'Annee Gerontologique

Volumn 4, Issue 1, 2012, Pages 17-20

  Maziere S ^a   Gavazzi, G ^a,b   Paccalin, M ^c  

^a HÔPITAL MICHALLON   (France)

^b LABORATOIRE TIMC IMAG   (France)

^c POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

Frailty; Geriatrics; Infections

Indexed keywords

AGING; ARTICLE; BONE FRAGILITY; DISEASE ASSOCIATION; FRAIL ELDERLY; FUNCTIONAL STATUS; HUMAN; IMMUNITY; INFECTION; INFECTION RISK; PREVALENCE;

EID: 84860533987     PISSN: 17605342     EISSN: 17605350     Source Type: Journal    
DOI: 10.1007/s12612-012-0255-4     Document Type: Article

References (42)

1. G. Gavazzi K.H. Krause 2002 Ageing and infection Lancet Infect Dis 2 659 666 12409046 10.1016/S1473-3099(02)00437-1
2. G. Gavazzi F. Herrmann K.H. Krause 2004 Aging and infectious diseases in the developing world Clin Infect Dis 39 83 91 15206058 10.1086/421559
3. M.L. Jackson K.M. Neuzil W.W. Thompson 2004 The burden of community-acquired pneumonia in seniors: results of a population-based study Clin Infect Dis 39 1642 1650 15578365 10.1086/425615
4. S. Tal V. Guller S. Levi, et al. 2005 Profile and prognosis of febrile elderly patients with bacteremic urinary tract infection J Infect 50 296 305 15845427 10.1016/j.jinf.2004.04.004
5. V. Kaplan D.C. Angus M.F. Griffin, et al. 2002 Hospitalized community-acquired pneumonia in the elderly: age- and sexrelated patterns of care and outcome in the United States Am J Respir Crit Care Med 165 766 772 11897642
6. S. Yende D.C. Angus I.S. Ali, et al. 2007 Influence of comorbid conditions on long-term mortality after pneumonia in older people J Am Geriatr Soc 55 518 525 17397429 10.1111/j.1532-5415.2007.01100.x
7. S. Ewig N. Birkner R. Strauss, et al. 2009 New perspectives on community-acquired pneumonia in 388406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality Thorax 64 1062 1069 19454409 10.1136/thx.2008.109785 1:STN:280:DC%2BD1MjptlWnsw%3D%3D
8. G. Gavazzi M.R. Mallaret P. Couturier, et al. 2002 Bloodstream infection: differences between young-old, old, and old-old patients J Am Geriatr Soc 50 1667 1673 12366620 10.1046/j.1532-5415.2002.50458.x
9. W.I. Sligl S.R. Majumdar 2011 How important is age in defining the prognosis of patients with community-acquired pneumonia? Curr Opin Infect Dis 24 142 147 21252659 10.1097/QCO.0b013e328343b6f8
10. E. Cretel I. Veen A. Pierres, et al. 2010 Immunosénescence et infections, mythe ou réalité ? Med Mal Infect 40 307 318 20092974 10.1016/j.medmal.2009.12.008 1:STN:280:DC%2BC3cnotFajtw%3D%3D
11. T. Fulop A. Larbi A. Wikby, et al. 2005 Dysregulation of T-cell function in the elderly: scientific basis and clinical implications Drugs Aging 22 589 603 16038574 10.2165/00002512-200522070-00005
12. R.D. Kovaiou D. Herndler-Brandstetter B. Grubeck-Loebenstein 2007 Age-related changes in immunity: implications for vaccination in the elderly Expert Rev Mol Med 9 1 17 17266794 10.1017/S1462399407000221
13. N. Weng A.N. Akbar J. Goronzy 2009 CD28(-) T cells: their role in the age-associated decline of immune function Trends Immunol 30 306 312 19540809 10.1016/j.it.2009.03.013 1:CAS:528:DC%2BD1MXotF2gtro%3D
14. D. Aw A.B. Silva D.B. Palmer 2007 Immunosenescence: emerging challenges for an ageing population Immunology 120 435 446 17313487 10.1111/j.1365-2567. 2007.02555.x 1:CAS:528:DC%2BD2sXktVOmtL4%3D
15. G. Pawelec A. Larbi 2008 Immunity and ageing in man: Annual Review 2006/2007 Exp Gerontol 43 34 38 17977683 1:CAS:528:DC%2BD2sXhsVCgsrnM
16. S.X. Leng 2011 Role of chronic cytomegalovirus infection in Tcell immunosenescence and frailty: more questions than answers J Am Geriatr Soc 59 2363 2365 22188078 10.1111/j.1532-5415.2011.03815.x
17. A.E. Aiello M.N. Haan C.M. Pierce, et al. 2008 Persistent infection, inflammation, and functional impairment in older Latinos J Gerontol A Biol Sci Med Sci 63 610 618 18559636 10.1093/gerona/63.6.610
18. G.C. Wang W.H. Kao P. Murakami, et al. 2010 Cytomegalovirus infection and the risk of mortality and frailty in older women: a prospective observational cohort study Am J Epidemiol 171 1144 1152 20400465 10.1093/aje/kwq062
19. L.P. Fried C.M. Tangen J. Walston, et al. 2001 Frailty in older adults: evidence for a phenotype J Gerontol A Biol Sci Med Sci 56 M146 M156 11253156 10.1093/gerona/56.3.M146 1:STN:280:DC%2BD3M7osFejuw%3D%3D
20. H.N. Schmaltz L.P. Fried Q.L. Xue, et al. 2005 Chronic cytomegalovirus infection and inflammation are associated with prevalent frailty in community-dwelling older women J Am Geriatr Soc 53 747 754 15877548 10.1111/j.1532-5415.2005.53250.x
21. C. Matheï B. Vaes P. Wallemacq, et al. 2011 Associations between cytomegalovirus infection and functional impairment and frailty in the BELFRAIL Cohort J Am Geriatr Soc 59 2201 2208 22092044 10.1111/j.1532-5415.2011.03719.x
22. Moro-Garcia MA, Olonso-Arias R, Lopez-Vazquez A, et al (2011) Relationship between functional ability in older people, immune system status, and intensity of response to CMV. Age (Dordr) (in press)
23. Bourdel-Marchasson F. Kraus G. Pinganaud, et al. 2001 Incidence annuelle et facteurs de risque d'infections nosocomiales bactériennes en unité gériatrique aigue Rev Med Interne 22 1056 1063 11817118 10.1016/S0248-8663(01)00471-4 1:STN:280:DC%2BD38%2FovVKltg%3D%3D
24. T.Y. Chen D.J. Anderson T. Chopra, et al. 2010 Poor functional status is an independent predictor of surgical site infections due to methicillin- resistant Staphylococcus aureus in older adults J Am Geriatr Soc 58 527 532 20158557 10.1111/j.1532-5415.2010.02719.x
25. C.J. Büla G. Ghilardi V. Wietlisbach, et al. 2004 Infections and functional impairment in nursing home residents: a reciprocal relationship J Am Geriatr Soc 52 700 706 15086648 10.1111/j.1532-5415.2004.52205.x
26. O.H. Torres J. Munoz D. Ruiz, et al. 2004 Outcome predictors of pneumonia in elderly patients: importance of functional assessment J Am Geriatr Soc 52 1603 1609 15450034 10.1111/j.1532-5415.2004.52492.x
27. F. Deulofeu B. Cervello S. Capell, et al. 1998 Predictors of mortality in patients with bacteremia: the importance of functional status J Am Geriatr Soc 46 14 14 9434660 1:STN:280:DyaK1c%2Fps1aksQ%3D%3D
28. G. Gavazzi P. Escobar F. Olive, et al. 2005 Nosocomial bacteremia in very old patients: predictors of mortality Aging Clin Exp Res 17 337 342 16285201
29. B.S. Chin M.S. Kim S.H. Han, et al. 2011 Risk factors of all-cause in-hospital mortality among Korean elderly bacteremic urinary tract infection (UTI) patients Arch Gerontol Geriatr 52 1 e50 e55 20579748 10.1016/j.archger. 2010.05.011
30. K.S. Kaye D. Marchaim T.Y. Chen, et al. 2011 Predictors of nosocomial bloodstream infections in older adults J Am Geriatr Soc 59 622 627 21366545 10.1111/j.1532-5415.2010.03289.x
31. A. El Sohl L. Pineda P. Bouquin, et al. 2006 Determinants of short and long term functional recovery after hospitalization for community-acquired pneumonia in the elderly: role of inflammatory markers BMC Geriatr 6 12 10.1186/1471-2318-6-12
32. B. Grubeck-Loebenstein S. Della Bella A.M. Iorio, et al. 2009 Immunosenescence and vaccine failure in the elderly Aging Clin Exp Res 21 201 209 19571643 1:CAS:528:DC%2BD1MXpsFGrtb0%3D
33. T. Fulop G. Pawelec S. Castle, et al. 2009 Immunosenescence and vaccination in nursing home residents Clin Infect Dis 48 443 448 19140756 10.1086/596475
34. K. Nichol 2003 The efficacy, effectiveness and costeffectiveness of inactivated influenza virus vaccines Vaccine 21 1769 1775 12686092 10.1016/S0264-410X(03)00070-7
35. M.T. Osterholm N.S. Kelley A. Sommer, et al. 2012 Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis Lancet Infect Dis 12 36 44 22032844 10.1016/S1473-3099(11)70295-X
36. K. Goodwin C. Viboud Simonsen 2006 Antibody response to influenza vaccination in the elderly: a quantitative review Vaccine 24 1159 1169 16213065 10.1016/j.vaccine.2005.08.105 1:CAS:528:DC%2BD28Xhtleiurg%3D
37. A.R. Falsey J.J. Treanor N. Tornieporth, et al. 2011 Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older J Infect Dis 200 172 180 10.1086/599790
38. McElhaney JE, Zhou X, Talbot HK, et al (2012) The unmet need in the elderly: How immunosenescence, CMV infection, comorbidities and frailty are a challenge for the development of more effective influenza vaccines. Vaccine (in press)
39. D.L. Blank D.M. Bodansky A. Forbes, et al. 2010 Influenza vaccination of future healthcare workers: a cross-sectional study of uptake, knowledge and attitudes Vaccine 28 4668 4672 20451640 10.1016/j.vaccine.2010.04.066
40. P.R. Blank M. Schwenkglenks T.D. Szucs 2009 Vaccination coverage rates in eleven European countries during two consecutive influenza seasons J Infect 58 446 458 19446340 10.1016/j.jinf.2009.04.001
41. A. Vila-Corcoles I. Hospital-Guardiola O. Ochoa-Gondar, et al. 2010 Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older BMC Infect Dis 10 73 20298596 10.1186/1471-2334-10-73
42. M.N. Oxman M.J. Levin G.R. Johnson, et al. 2005 A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults N Engl J Med 352 2271 2284 15930418 10.1056/NEJMoa051016 1:CAS:528:DC%2BD2MXksl2ltro%3D